IMPORTANT NOTICE: End of COVID-19 PHE
Mar. 2023Important Notices
IMPORTANT NOTICE: The Biden Administration has announced that the COVID-19 PHE is expected to end on May 11, 2023. Some benefits or flexibilities made available during the PHE will expire on that date. UPMC Health Plan will update this Appendix A with more information about expiring benefits prior to the end of the PHE.
Recent Announcements
CME Webinar: The State of Telehealth in 2026
Please join us for a live, CME-accredited webinar on Tuesday, Jan. 27, from noon to 1 p.m. that will share updates on the state of telehealth for 2026.Dec. 2025Education/Webinars
Formulary updates effective Jan. 1, 2026
Review upcoming policy and operational updatesDec. 2025Pharmacy Updates
Voluntary nationwide recall: Famotidine (Fresenius – November)
Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.Nov. 2025Pharmacy Updates